News from other sources
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content
Pharmaceuticals
Consort, Opiant to develop nasal spray for opioid overdose treatment | Reuters
The two companies will work together on a nasal-spray version of nalmefene. Opiant received a $7.4 million grant from the NIH earlier this year to develop the treatment.
Technology
Amazon and Apple are getting into medical clinics — here's why | CNBC
The companies want to keep healthcare costs down and test new products—and make some money too.
Opternative launches voice-based, smartphone-only vision test | Mobihealthnews
The voice recognition software comes from Google, IBM Watson, and Microsoft.
Medical devices
Payers join new FDA program to expedite medical device coverage | Health Data Management
BlueCross BlueShield Association, CareFirst BlueCross BlueShield, Humana, Kaiser Permanente and United Health Group are meeting with the FDA to speed up the regulatory process.
In other news
Serena Williams vs. Naomi Osaka: How the U.S. Open descended into chaos | The New York Times
"I don't cheat to win, I'd rather lose. I'm just letting you know," Williams told the chair umpire.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
1 | |
2 | |
3 | |
4 | |
5 |